Stockholm, Sweden

Bengt Ingemar Samuelsson

This inventor holds 9 USPTO granted patents and 14 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Jiangyin Bengt I. Samuelsson Institute of Life Science Co., Ltd., Enlitisa (Shanghai) Pharmaceutical Co., Ltd, Jiangyin Usun Pharmaceutical Co., Ltd.. Active years: 1985-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bengt Ingemar Samuelsson. Retrieved from https://idiyas.com/inventor/bengt-ingemar-samuelsson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 2.1

ph-index = 3

Forward Citations = 31(Granted Patents)


Location History:

  • 18263 Djursholm, SE (1985)
  • Stocklholm, SE (2020)
  • Stockholm, SE (2019 - 2023)

Company Filing History:


Years Active: 1985-2024

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Bengt Ingemar Samuelsson

Introduction: Bengt Ingemar Samuelsson, a distinguished inventor based in Stockholm, Sweden, has made significant strides in the field of medical science through his inventive work. With a total of nine patents to his name, Samuelsson's contributions focus on innovative treatments and therapeutic solutions.

Latest Patents: Among his latest patents, Samuelsson has developed a peptide that exhibits anti-inflammatory properties. This peptide has the sequence Ala-Lys-Pro-Ser-Tyr-Hyp-Hyp-Thr-DOPA-Lys or a salt thereof, and is aimed at treating various inflammatory disorders, including wounds, burns, psoriasis, acne, and atopic dermatitis. Another notable patent involves conjugates of montelukast and peptides, which describes a peptide-containing compound consisting of an amino acid sequence from 2 to 45 amino acids, covalently bonded to one or more compounds of a specified formula.

Career Highlights: Samuelsson has worked with prominent organizations, including Jiangyin Bengt I. Samuelsson Institute of Life Science Co., Ltd. and Enlitisa (Shanghai) Pharmaceutical Co., Ltd. His career is marked by a commitment to advancing medical treatments through his innovative inventions.

Collaborations: Throughout his career, Samuelsson has collaborated with notable coworkers such as Min Gao and Ming Gu, fostering a creative and productive environment that has led to significant advancements in his field.

Conclusion: Bengt Ingemar Samuelsson's innovative spirit and dedication to medical science are reflected in his patented inventions. His work continues to shape the landscape of therapeutic solutions, demonstrating the power of innovation and collaboration in the quest for medical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…